Objective-UVB irradiation is an established treatment for immunoinflammatory cutaneous disorders and has been shown to suppress cutaneous and systemic inflammatory diseases through modulation of the adaptive immune response. However, it remains unknown whether UVB irradiation prevents an immunoinflammatory disease of arteries such as atherosclerosis. Approach and Results-Here, we show that UVB exposure inhibits the development and progression of atherosclerosis in atherosclerosis-prone mice by expanding and enhancing the functional capacity of CD4 + forkhead box P3 + regulatory T cells and regulating proatherogenic T-cell responses. Experimental studies in Langerhans cell-depleted mice revealed that epidermal Langerhans cells play a critical role in UVB-dependent induction of CD4 + forkhead box P3 + regulatory T cells, suppression of proatherogenic T-cell responses, and prevention of atherosclerotic plaque development. Conclusions-Our findings suggest the skin immune system as a novel therapeutic target for atherosclerosis and provide a novel strategy for the treatment and prevention of atherosclerosis. 
A therosclerotic disease including ischemic heart disease and stroke is a major cause of mortality in developed countries. Atherosclerosis involves chronic inflammation of the arterial wall. 1 Innate and adaptive immune responses contribute to the development and rupture of unstable atherosclerotic plaques and subsequent thrombotic arterial occlusion, leading to fatal clinical events. Chronic vascular inflammation via T-cell-mediated immune responses is well known to play an important role in atherogenesis. 2 Recent experimental studies from several independent groups indicated that several subsets of regulatory T cells (Tregs) including forkhead box P3 (Foxp3)-expressing Tregs, which actively mediate immunologic tolerance, 3 play a role in preventing atherosclerosis by dampening proatherogenic T-cell responses or modulating lipoprotein metabolism, [4] [5] [6] revealing the importance of the balance between proatherogenic T cells and atheroprotective Tregs in the control of atherosclerotic diseases. 7 There is also increasing clinical evidence showing the dysregulation of this balance in human coronary atherosclerotic disease. 8, 9 It has long been known that UV irradiation critically affects the immune system. Numerous studies in the field of photoimmunology have reported that UV irradiation, in particular UVB, induces immunosuppression and dampens inflammatory reactions. 10 For evaluation of biological functions of UVB, several studies used mouse contact hypersensitivity model, in which UVB suppresses hapten-mediated contact hypersensitivity in an antigen-specific manner. 11 Interestingly, this phenomenon has been shown to be associated with generation of antigen-specific Tregs. 10 Langerhans cells (LCs) are the major antigen-presenting cells in the skin, 12 where the immune system is constantly stimulated by the environment and they regulate adaptive immune responses in response to various stimuli. Recent studies suggest that epidermal LCs undergo morphological changes and alter their function during UVB-induced immunosuppression. 13, 14 Despite advances in our understanding of the chronic immunoinflammatory nature of atherosclerosis, therapeutics aimed to intervene inflammation or immune system remains to be implemented in clinical practice. UVB-based phototherapy is the firstline treatment for immunoinflammatory cutaneous disorders such as psoriasis in humans without serious side effects. 15 Here, we investigated the effect of UVB irradiation on atherosclerosis and its underlying mechanisms in hypercholesterolemic mice. Our findings provide first evidence that UVB exposure inhibits the development and progression of atherosclerosis. Using hypercholesterolemic LC-depleted mice, we clearly demonstrated that epidermal LCs play a critical role in UVB-dependent induction of CD4 +
Foxp3
+ Tregs, suppression of proatherogenic T-cell responses, and prevention of atherosclerotic plaque development. Our data suggest that UVB-based modulation of the skin immune system for inducing atheroprotective Tregs may be an attractive approach to treat and prevent atherosclerosis.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

UVB Irradiation Inhibits the Initiation and Progression of Atherosclerotic Plaque Formation in Atherosclerotic Mice
To study the effect of UVB irradiation on the development of atherosclerosis, apolipoprotein E-deficient (Apoe −/− ) mice were irradiated with 2 or 5 kJ/m 2 UVB once weekly for 14 weeks. During the experiments, severe adverse effects such as skin cancer or skin inflammation were not observed following UVB exposure. UVB irradiation did not affect body weight and plasma lipid profile (Table I in the online-only Data Supplement). We found a significant increase in biologically active 1,25-dihydroxyvitamin D plasma levels, whereas plasma levels of circulating storage form 25-hydroxyvitamin D were unaffected (Table I in Figure 1A . In parallel with the cross-sectional studies, en face analysis of thoracoabdominal aortas revealed a significant reduction in aortic plaque burden at 20 weeks in 5 kJ/m 2 UVB-irradiated mice (mean±SD, 2.62±0.85%; P=0.0041 versus controls) compared with control mice (mean±SD, 5.13±1.84%; Figure 1B ). There was a tendency toward reduction in atherosclerotic plaque even in 2 kJ/m 2 UVB-irradiated mice (mean±SD, 3.63±1.56%; P=0.1023 versus controls; Figure 1B) .
To determine the effects of UVB irradiation on plaque component, we next performed immunohistochemical studies of atherosclerotic lesions in the aortic sinus. Interestingly, the atherosclerotic lesions of UVB-irradiated mice showed a marked reduction in the accumulation of macrophages and a significant decrease in CD4 + T-cell infiltration ( Figure 1C To determine the function of UVB-induced Tregs, we investigated the effects of UVB irradiation on the expression of Treg-associated molecules in CD4 +
Foxp3
+ Tregs in LNs and spleen using flow cytometry. Interestingly, UVB-induced CD4 + Foxp3
+ Tregs expressed higher levels of typical Treg markers including cytotoxic T lymphocyte-associated antigen-4 and CD103, while CD25 and glucocorticoid-induced tumor necrosis factor receptor family-related gene/protein were expressed at equivalent levels to those from nonirradiated mice ( Figure 2B and 2C). Among various suppression mechanisms, 3 cytotoxic T lymphocyte-associated antigen-4 is known to be constitutively expressed by CD4 +
+ Tregs as a core mechanism for Treg-mediated suppression. 16 Therefore, we examined a possibility that UVB treatment might enhance the suppressive function in each Treg. The in vitro suppression assay revealed that Tregs from UVB-irradiated mice had higher suppressive capacity compared with those from controls ( Figure 2D ). Dendritic cells (DCs) express costimulatory molecules such as B7-1 (CD80) and B7-2 (CD86) that bind to receptors on the T cells simultaneously with antigen recognition, which leads to T-cell activation. Downregulation of CD80 and CD86 expression on DCs by cytotoxic T lymphocyte-associated antigen-4 is reported to be a key mechanism for Treg-mediated suppression. 16 Interestingly, effector T-cell-dependent upregulation of CD80 and CD86 expression on splenic CD11c + DCs was suppressed by cocultured Tregs, and UVB irradiation enhanced the suppression ( Figure 2E ).
To determine whether induction of CD4 Cytokine production from splenic lymphocytes was examined by ELISA. n=5 per group. G, To examine the effect of long-term UVB irradiation on cytokine production from splenic lymphocytes, 6-wk-old Apoe −/− mice were irradiated with 2 or 5 kJ/m 2 UVB once weekly for 14 wk. Cytokine production from splenic lymphocytes was measured as described above. n=5 per group. Data are representative of 2 independent experiments (A-F). Data points represent individual animals (A-C, F, G) . Horizontal bars represent means (A-C, E-G). *P<0.05; **P<0.01; Mann-Whitney U test (A-C, F, G) and 2-tailed Student t test (E). CTLA-4 indicates cytotoxic T lymphocyte-associated antigen-4; and GITR, glucocorticoid-induced tumor necrosis factor receptor family-related gene/protein. The important role of epidermal-resident antigen-presenting LCs in UVB-induced immune suppression has been reported, 13, 14 but it is still unclear whether they are essential for Treg induction on UVB exposure. LC might play a role in UVB-mediated atherosclerosis reduction although no reports have directly approached this possibility to date. It is reported that UVB exposure triggers the migration of LCs from the skin to the draining LNs in normocholesterolemic mice, where they may induce immunologic tolerance. 13 Consistent with this report, we found that UVB irradiation reduced the number of LCs in the epidermis ( Figure To specifically evaluate the role of LCs on UVB exposure, we used Lang-DTR mice expressing a diphtheria toxin (DT) receptor fused to enhance green fluorescent protein under the control of the langerin gene, 17 on an Apoe −/− background. Recent studies have identified a population of langerin + DCs in the dermis, 18 which is distinct from LCs in the epidermis although functional differences between these 2 populations have not been fully elucidated. In agreement with the previous report, 18 DT administration to Lang-DTR/Apoe −/− mice resulted in complete ablation of both dermal langerin + DCs and epidermal LCs on day 2, whereas half of dermal langerin + DCs, but none of epidermal LCs, were recovered on day 9 ( Figure 3A) , which provided us with the opportunity to assess the role of epidermal LCs in UVB-dependent atheroprotection. To determine the effect of UVB irradiation on CD4 Figure 3C ), whereas IFN-γ production was inhibited in LC-sufficient mice after UVB irradiation (Figures 2F and  3C) . These results collectively suggest that epidermal LCs are indispensable for UVB-mediated CD4 +
+ Treg induction and suppression of proatherogenic T-cell responses in lymphoid organs under hypercholesterolemia.
Epidermal LCs Play a Critical Role in UVB-Dependent Prevention of Intraplaque Accumulation of Inflammatory Cells and Atherosclerosis Development
We further investigated the effect of UVB irradiation on atherosclerosis development under LC-depleted conditions.
There was no significant difference in body weight and plasma lipid profile between UVB-irradiated and nonirradiated mice regardless of LC depletion (Table II in the online-only Data Supplement). We found that UVB irradiation did not affect atherosclerotic lesion size in the aortic root ( Figure 4A ) or intraplaque accumulation of inflammatory cells including macrophages ( Figure 4B ) and CD4 + T cells ( Figure 4C ) in DT-treated Lang-DTR/Apoe −/− mice, whereas we observed a marked decrease in atherosclerotic lesion formation in UVBirradiated Apoe −/− mice treated with DT ( Figure 4A ) and UVBirradiated Lang-DTR/Apoe −/− mice treated with PBS ( Figure 
Discussion
Although compelling evidence suggests that chronic immunoinflammatory responses are deeply involved in the pathogenesis of atherosclerosis, we have no therapeutics aimed to intervene inflammation or immune system in clinical practice. In the current study, we demonstrate that UVB exposure prevents atherosclerosis by enhancing a regulatory immune response and suppressing proatherogenic immune responses in hypercholesterolemic mice. Experimental studies in LC-depleted mice clearly demonstrated that induction of atheroprotective CD4 +
Foxp3
+ Tregs by UVB-mediated modulation of epidermal LC function is critical for prevention of atherosclerosis, suggesting the skin immune system as a novel therapeutic target for atherosclerosis ( Figure IV in the onlineonly Data Supplement).
Epidemiological studies have suggested a possible link between cardiovascular disease and sunlight exposure. [19] [20] [21] One possible explanation for this phenomenon may be decreased levels of immunosuppressive vitamin D. 22 In addition to inadequate dietary intake of vitamin D, limited sunlight exposure is one of the major causes of low vitamin D levels because UVB plays an important role in cutaneous synthesis of vitamin D. Notably, a recent epidemiological study has shown a relationship between low plasma levels of vitamin D and a predisposition to cardiovascular events. 23 Our recent experimental study has demonstrated that oral administration of active form of vitamin D decreases atherosclerosis in hypercholesterolemic mice by promoting induction of tolerogenic DCs and CD4 + Foxp3 + Tregs. 24 These studies suggest the possibility that increased plasma levels of vitamin D may contribute to the expansion of Tregs and reduction of atherosclerosis development after UVB exposure. Despite increased plasma levels of biologically active vitamin D (Table II in the online-only Data Supplement), UVB-mediated atheroprotective effects were abrogated on LC depletion, excluding a substantial contribution of increased plasma vitamin D levels to atherosclerosis reduction in our model. Thus, we identified a novel mechanism for UVB-dependent atheroprotection although the differences in its metabolism and atheroprotective properties between mice and humans remain unclear and further clarification is required. However, we cannot exclude that increased local vitamin D levels in the skin might influence LC function and be involved in UVB-dependent induction of CD4 +
+ Tregs and prevention of atherosclerosis development because 1,25-dihydroxyvitamin D is reported to be a strong inducer of receptor activator of nuclear factor-κB ligand, 25 which might be important for UVB-dependent CD4 +
+ Treg induction in the skin. 26 Inflammation in the arterial wall is an important hallmark of atherosclerosis. Innate and adaptive immunities have been shown to substantially contribute to driving inflammation involved in the pathogenesis of atherosclerosis. Although critical antigens responsible for driving atherosclerosis remain unclear, naive T cells differentiate into effector T cells including the Th1, Th2, and Th17 lineage after antigen presentation by antigen-presenting cells such as DCs. Th1-mediated immune responses such as production of inflammatory cytokine IFN-γ are known to drive atherosclerosis, whereas the roles of Th2 or Th17-mediated immune responses may vary depending on their producing cytokines or animal model used and are still controversial. 2 UVB irradiation has been shown to suppress cutaneous and systemic inflammatory diseases by modulating Th1 and Th2 immune responses, which may vary depending on disease models used. [27] [28] [29] Here, we provide first evidence that proatherogenic Th1 immune responses were specifically suppressed after UVB irradiation in hypercholesterolemic mice, in association with marked expansion of activated CD4 +
+ Tregs, whereas Th2 and Th17 immune responses were not affected. Our data suggest that UVB-dependent favorable modulation of the balance between proatherogenic T cells and atheroprotective Tregs may substantially contribute to the prevention of atherosclerosis. We found that expansion of polyclonal-activated CD4 + Foxp3 + Tregs are effective enough to prevent proatherogenic immune responses and atherosclerosis development. Given that topical application of haptens onto UVB-exposed skin induces hapten-specific Tregs and inhibit contact hypersensitivity, 28 it is intriguing to speculate that development of antigen-specific Tregs using this method may be more efficacious in preventing atherosclerosis. We expect that such tolerance-inducing therapy could be an attractive approach for the treatment of atherosclerosis not only in mice but also in humans, avoiding unwanted general immunosuppression. To accomplish this, future work should clarify the true antigens responsible for driving atherosclerosis although some antigens have already been shown to be involved in the pathogenesis of experimental atherosclerosis.
DCs are a heterogeneous group of professional antigenpresenting cells involved in induction of immune responses and immune tolerance. Skin-resident DCs are divided into several groups including epidermal LCs and langerin + or langerin -dermal DCs. 30 Recent evidence suggests that LCs not only induces adaptive immune responses against invading pathogens but also maintains immune tolerance. 30 Using hypercholesterolemic LC-depleted mice, we have clearly shown that epidermal LCs are critical for UVB-mediated CD4 +
+ Treg induction and suppression of proatherogenic T-cell responses under hypercholesterolemia. However, we cannot exclude that other DC subsets such as CD8α + DCs might also be involved in UVB-mediated atheroprotective effects because some of these DCs express langerin and are depleted in this mouse model. 17 Receptor activator of nuclear factor -κB ligand is expressed in keratinocytes of the skin and is crucial for the peripheral homeostasis of CD4 26 UVB exposure induces acute inflammation and DNA damage in the skin, 10, 31 which causes activation of epidermal LCs through the upregulation of epidermal receptor activator of nuclear factor -κB ligand expression in keratinocytes. 26 Future work examining more detailed molecular mechanisms for UVB-dependent Treg induction will enable us to design novel therapies for atherosclerotic disease through modulating the skin immune system.
UV-based phototherapy and photochemotherapy have been shown to be established treatments for a large number of immunoinflammatory cutaneous disorders including psoriasis, atopic dermatitis, and cutaneous T-cell lymphoma in humans without severe adverse effects. Recent clinical studies have shown expansion of peripheral CD4 + CD25 + Foxp3 + Tregs in patients with skin autoimmune disease after UVB phototherapy. 32, 33 Based on our data and previous studies, we suppose that UVB phototherapy might be beneficial in treating or preventing human atherosclerosis through expansion of CD4 +
+ Tregs although the role of Tregs in human atherosclerotic disease has not been fully elucidated. Because excessive UVB exposure may have potential hazardous effects such as skin cancer and exacerbation of infectious diseases, careful management is required for application in clinical settings.
In conclusion, we show that UVB exposure prevents atherosclerosis by expanding and enhancing the functional capacity of atheroprotective CD4 +
+ Tregs and suppressing proatherogenic immune responses and provide evidence that epidermal LCs play an important role in these processes. Although we should be cautious with extrapolation of our data to the human system, our findings may provide a novel strategy for the treatment and prevention of atherosclerosis.
